Veneno Technologies is a research and development of therapeutic disulfide-rich peptides and medicines.
Veneno Technologies has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in January 2022.
Veneno Technologies's investors include SBI Investment, Tsukuba Institute of Research, SBI regional activation support Co., Ltd..
Veneno Technologies is headquartered in Tsukuba, Japan.
Veneno Technologies is a research and development of therapeutic disulfide-rich peptides and medicines.
Veneno Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Veneno Technologies — Funding & Investors." VCBacked, January 24, 2022, https://www.vcbacked.co/company/veneno-technologies. Accessed August 14, 2026.
VCBacked. (2022). Veneno Technologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/veneno-technologies
{{cite web |title=Veneno Technologies — Funding & Investors |url=https://www.vcbacked.co/company/veneno-technologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated